Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Scarr

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
The Australian and New Zealand Journal of Psychiatry|February 16, 2006
Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophreniaBrian Dean, Laura Gray, Elizabeth Scarr
Schizophrenia Research|April 20, 2023
Lower levels of cortical [<sup>3</sup>H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficitsBrian Dean, Vahram Haroutunian, Elizabeth Scarr
BMC Psychiatry|May 22, 2016
Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophreniaBrian Dean, Madhara Udawela, Elizabeth Scarr
NPJ Schizophrenia|February 22, 2018
Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophreniaElizabeth Scarr, Madhara Udawela, Brian Dean
Psychiatry Research|May 21, 2010
Effects of benzodiazepine treatment on cortical GABA(A) and muscarinic receptors: studies in schizophrenia and ratsMark C McLeod, Elizabeth Scarr, Brian Dean
Schizophrenia Research|July 20, 2014
An investigation of the factors that regulate muscarinic receptor expression in schizophreniaMyoung Suk Seo, Elizabeth Scarr, Brian Dean
Journal of Affective Disorders|June 5, 2003
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorderBrian Dean, Elizabeth Scarr, Geoffrey Pavey, et al.
Life Sciences|October 11, 2005
No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophreniaElizabeth Scarr, Dahlia Keriakous, Nicola Crossland, et al.
Schizophrenia Research|October 8, 2010
Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophreniaAdel Barakat, Brian Dean, Elizabeth Scarr, et al.
Schizophrenia Research|October 12, 2004
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patientsCarmit Nadri, Brian Dean, Elizabeth Scarr, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
The Australian and New Zealand Journal of Psychiatry|February 16, 2006
Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophreniaBrian Dean, Laura Gray, Elizabeth Scarr
Schizophrenia Research|April 20, 2023
Lower levels of cortical [<sup>3</sup>H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficitsBrian Dean, Vahram Haroutunian, Elizabeth Scarr
BMC Psychiatry|May 22, 2016
Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophreniaBrian Dean, Madhara Udawela, Elizabeth Scarr
NPJ Schizophrenia|February 22, 2018
Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophreniaElizabeth Scarr, Madhara Udawela, Brian Dean
Psychiatry Research|May 21, 2010
Effects of benzodiazepine treatment on cortical GABA(A) and muscarinic receptors: studies in schizophrenia and ratsMark C McLeod, Elizabeth Scarr, Brian Dean
Schizophrenia Research|July 20, 2014
An investigation of the factors that regulate muscarinic receptor expression in schizophreniaMyoung Suk Seo, Elizabeth Scarr, Brian Dean
Journal of Affective Disorders|June 5, 2003
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorderBrian Dean, Elizabeth Scarr, Geoffrey Pavey, et al.
Life Sciences|October 11, 2005
No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophreniaElizabeth Scarr, Dahlia Keriakous, Nicola Crossland, et al.
Schizophrenia Research|October 8, 2010
Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophreniaAdel Barakat, Brian Dean, Elizabeth Scarr, et al.
Schizophrenia Research|October 12, 2004
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patientsCarmit Nadri, Brian Dean, Elizabeth Scarr, et al.
Pageof 10